Page 82 - 南京医科大学自然版
P. 82

第44卷第11期
               ·1548 ·                           南 京    医 科 大 学 学         报                        2024年11月


              研究结果显示基线脂联素和瘦素检测在PA 的精准                           [10]NISHIZAKA M K,ZAMAN M A,GREEN S A,et al. Im⁃
              管理中可能具有筛选和预测价值。未来大样本的                                  paired endothelium ⁃ dependent flow ⁃ mediated vasodila⁃
              队列研究可进一步明确脂联素和瘦素在预测PA 靶                                tion in hypertensive subjects with hyperaldosteronism[J].
              器官损害和术后临床转归中的价值,以期应用于临                                 Circulation,2004,109(23):2857-2861
                                                                [11]KEIDAR S,KAPLAN M,PAVLOTZKY E,et al. Aldoste⁃
              床。此外,本研究结果也侧面提示了脂联素和瘦素
                                                                     rone administration to mice stimulates macrophage
              在 PA 病理生理机制中的作用,为 PA 的治疗提供了
                                                                     NADPH oxidase and increases atherosclerosis develop⁃
              潜在的靶点信息。
                                                                     ment:a possible role for angiotensin ⁃ converting enzyme
             [参考文献]                                                  and the receptors for angiotensin Ⅱ and aldosterone[J].
                                                                     Circulation,2004,109(18):2213-2220
             [1] MONTICONE S,D’ASCENZO F,MORETTI C,et al. Car⁃
                                                                [12]ROCHA R,STIER C T J R,KIFOR I,et al. Aldosterone:a
                   diovascular events and target organ damage in primary
                                                                     mediator of myocardial necrosis and renal arteriopathy[J].
                   aldosteronism compared with essential hypertension:a
                                                                     Endocrinology,2000,141(10):3871-3878
                   systematic review and meta⁃analysis[J]. Lancet Diabetes
                                                                [13] FALLO F,PILON C,URBANET R. Primary aldostero ⁃
                   Endocrinol,2018,6(1):41-50
                                                                     nism and metabolic syndrome[J]. Horm Metab,2012,44
             [2] WILLIAMS T A,LENDERS J W M,MULATERO P,et al.
                                                                    (3):208-214
                   Outcomes after adrenalectomy for unilateral primary aldo⁃
                                                                [14]ADLER G K,MURRAY G R,TURCU A F,et al. Primary
                   steronism:an international consensus on outcome mea⁃
                                                                     aldosteronism decreases insulin secretion and increases
                   sures and analysis of remission rates in an international
                                                                     insulin clearance in humans[J]. Hypertension,2020,75
                   cohort[J]. Lancet Diabetes Endocrinol,2017,5(9):689-
                                                                    (5):1251-1259
                   699
                                                                [15]HU J B,SHEN H,HUO P Q,et al. Heightened cardiovas⁃
             [3] RUIZ ⁃ SÁNCHEZ J G,PAJA ⁃ FANO M,GONZÁLEZ
                   BOILLOS M,et al. Effect of obesity on clinical characte⁃  cular risk in hypertension associated with renin⁃indepen⁃
                                                                     dent aldosteronism versus renin⁃dependent aldosteronism:
                   ristics of primary aldosteronism patients at diagnosis and
                   postsurgical response[J]. J Clin Endocrinol Metab,2023,  a collaborative study[J]. J Am Heart Assoc,2021,10
                   109(1):e379-e388                                 (24):e023082
                                                                [16]HU J B,CHEN X J,LUO Y,et al. Renin⁃independent
             [4] ZHAO S G,KUSMINSKI C M,SCHERER P E. Adiponec⁃
                   tin,leptin and cardiovascular disorders[J]. Circ Res,2021,  aldosteronism and chronic kidney disease in diabetes:
                   128(1):136-149                                    observational and Mendelian randomization analyses[J].
             [5] IACOBELLIS G,PETRAMALA L,COTESTA D,et al.           Metabolism,2023,145:155593
                   Adipokines and cardiometabolic profile in primary hyper⁃  [17] HUNDEMER G L,AGHARAZII M,MADORE F,et al.
                   aldosteronism[J]. J Clin Endocrinol Metab,2010,95(5):  Subclinical primary aldosteronism and cardiovascular
                   2391-2398                                         health:a population⁃based cohort study[J]. Circulation,
             [6] 中华医学会内分泌学分会. 原发性醛固酮增多症诊断                            2024,149(2):124-134
                   治疗的专家共识(2020 版)[J]. 中华内分泌代谢杂志,               [18] FAULKNER J L,BRUDER ⁃ NASCIMENTO T,BELIN
                   2020,36(9):727-736                                DE CHANTEMÈLE E J. The regulation of aldosterone
             [7] REINCKE M,MEISINGER C,HOLLE R,et al. Is primary     secretion by leptin:implications in obesity⁃related cardio⁃
                   aldosteronism associated with diabetes mellitus? Results  vascular disease[J]. Curr Opin Nephrol Hypertens,
                   of the German Conn’s Registry[J]. Horm Metab,2010,  2018,27(2):63-69
                   42(6):435-439                                [19] HUBY A C,ANTONOVA G,GROENENDYK J,et al.
             [8] HANSLIK G,WALLASCHOFSKI H,DIETZ A,et al.            Adipocyte⁃derived hormone leptin is a direct regulator of
                   Increased prevalence of diabetes mellitus and the meta⁃  aldosterone secretion,which promotes endothelial dys⁃
                   bolic syndrome in patients with primary aldosteronism of  function and cardiac fibrosis[J]. Circulation,2015,132
                   the German Conn’s Registry[J].Eur J Endocrinol,2015,  (22):2134-2145

                   173(5):665-675                               [20]PACKER M. Leptin⁃aldosterone⁃neprilysin axis:identifi⁃
             [9] ROCHA R,MARTIN⁃BERGER C L,YANG P C,et al.           cation of its distinctive role in the pathogenesis of the three
                   Selective aldosterone blockade prevents angiotensin Ⅱ/  phenotypes of heart failure in people with obesity[J].
                   salt ⁃ induced vascular inflammation in the rat heart[J].  Circulation,2018,137(15):1614-1631
                   Endocrinology,2002,143(12):4828-4836         [21]YOZAMP N,HUNDEMER G L,MOUSSA M,et al. Intra⁃
   77   78   79   80   81   82   83   84   85   86   87